PE20010238A1 - GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS SodC, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS - Google Patents
GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS SodC, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOSInfo
- Publication number
- PE20010238A1 PE20010238A1 PE2000000445A PE0004452000A PE20010238A1 PE 20010238 A1 PE20010238 A1 PE 20010238A1 PE 2000000445 A PE2000000445 A PE 2000000445A PE 0004452000 A PE0004452000 A PE 0004452000A PE 20010238 A1 PE20010238 A1 PE 20010238A1
- Authority
- PE
- Peru
- Prior art keywords
- polypeptide
- sodc
- amino acid
- cell
- acid sequence
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 11
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 8
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 241001469654 Lawsonia <weevil> Species 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 150000001413 amino acids Chemical group 0.000 abstract 4
- 108010038807 Oligopeptides Proteins 0.000 abstract 2
- 102000015636 Oligopeptides Human genes 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 230000001681 protective effect Effects 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 108010006464 Hemolysin Proteins Proteins 0.000 abstract 1
- 241001148567 Lawsonia intracellularis Species 0.000 abstract 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000003228 hemolysin Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13398999P | 1999-05-13 | 1999-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010238A1 true PE20010238A1 (es) | 2001-03-03 |
Family
ID=22461256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000000445A PE20010238A1 (es) | 1999-05-13 | 2000-05-12 | GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS SodC, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1177212A4 (fr) |
| JP (1) | JP2003501013A (fr) |
| AR (1) | AR023975A1 (fr) |
| AU (1) | AU4385800A (fr) |
| BR (1) | BR0011292A (fr) |
| CA (1) | CA2372095A1 (fr) |
| MX (1) | MXPA01011670A (fr) |
| NZ (1) | NZ515332A (fr) |
| PE (1) | PE20010238A1 (fr) |
| WO (1) | WO2000069903A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605696B1 (en) | 1999-10-22 | 2003-08-12 | Pfizer, Inc. | Lawsonia intracellularis proteins, and related methods and materials |
| EP1586646B1 (fr) | 2000-12-20 | 2011-03-09 | Intervet International BV | Lawsonia intracellularis vaccin |
| BRPI0413857A (pt) * | 2003-09-12 | 2006-10-24 | Akzo Nobel Nv | seqüência de ácido nucleico, fragmento de dna, molécula de dna recombinante, veìculo recombinante vivo, célula hispedeira, proteìna de lawsonia intracellularis, uso de uma proteìna de lawsonia intracellularis, vacina para combater infecções por lawsonia intracellularis, método para a preparação de uma vacina, e, teste diagnóstico |
| EP1709067B1 (fr) * | 2004-01-22 | 2010-06-09 | Intervet International BV | Vaccin a sous-unité de lawsonia intracellularis |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| US8398994B2 (en) | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
| US20100129397A1 (en) | 2006-12-11 | 2010-05-27 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
| CN111830257B (zh) * | 2020-07-17 | 2023-10-24 | 南京农业大学 | 一种猪源胞内劳森菌ipma抗原检测方法及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5885823A (en) * | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| NZ322398A (en) * | 1995-11-30 | 2000-02-28 | Pig Res & Dev Corp | Vaccine compositions comprising non-pathogenic form of Lawsonia intracellularis, nucleic acid sequences thereof and treatment of intestinal disease |
-
2000
- 2000-05-11 WO PCT/AU2000/000436 patent/WO2000069903A1/fr not_active Application Discontinuation
- 2000-05-11 JP JP2000618319A patent/JP2003501013A/ja active Pending
- 2000-05-11 BR BR0011292-5A patent/BR0011292A/pt not_active IP Right Cessation
- 2000-05-11 AU AU43858/00A patent/AU4385800A/en not_active Abandoned
- 2000-05-11 CA CA002372095A patent/CA2372095A1/fr not_active Abandoned
- 2000-05-11 NZ NZ515332A patent/NZ515332A/xx unknown
- 2000-05-11 EP EP00924975A patent/EP1177212A4/fr not_active Withdrawn
- 2000-05-11 MX MXPA01011670A patent/MXPA01011670A/es unknown
- 2000-05-12 AR ARP000102294A patent/AR023975A1/es unknown
- 2000-05-12 PE PE2000000445A patent/PE20010238A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1177212A1 (fr) | 2002-02-06 |
| MXPA01011670A (es) | 2003-10-14 |
| NZ515332A (en) | 2004-01-30 |
| EP1177212A4 (fr) | 2002-08-28 |
| AR023975A1 (es) | 2002-09-04 |
| BR0011292A (pt) | 2002-02-26 |
| AU4385800A (en) | 2000-12-05 |
| CA2372095A1 (fr) | 2000-11-23 |
| JP2003501013A (ja) | 2003-01-14 |
| WO2000069903A1 (fr) | 2000-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199800973A1 (ru) | Полипептид белка-106 наружной мембраны moraxella catarrhalis, последовательность гена и их применение | |
| IL133056A (en) | Polypeptide containing an immunogenic portion of an m. tuberculosis antigen, a variant thereof and pharmaceutical compositions containing same | |
| DE60332645D1 (de) | Ii-key/antigene epitop-hybrid-peptid-vakzine | |
| BRPI0412799A (pt) | imunógeno, composição, ácido nucleico, célula recombinante, métodos para preparar um polipeptìdeo, para induzir um a resposta imune protetora em um paciente e para induzir uma resposta anamnésica em um paciente, e, seqüência de ácido nucleico otimizada de levedura | |
| NZ331829A (en) | Clostridium perfringens vaccines | |
| TW200716166A (en) | Lawsonia intracellularis immunological proteins | |
| HU9203449D0 (en) | Varied cd44 surfacial proteins, dna sequences coding them, antibodies acting against these proteins as well as application of all these things in diagnostics and therapy | |
| SE9402089D0 (sv) | Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments | |
| PE20010238A1 (es) | GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS SodC, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS | |
| PE20020857A1 (es) | Proteinas de fusion cuya parte del n-terminal es un derivado de hirudina para la produccion de proteinas recombinantes a traves de la secresion por levaduras | |
| WO2002008716A3 (fr) | Procede de criblage de peptides utilisables en immunotherapie | |
| PE20010237A1 (es) | GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS OmpH, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS | |
| WO2003090667A3 (fr) | Composition immunogene ou vaccinale non immunosuppressive, comprenant une proteine e7 mutee du virus hpv-16 | |
| PE20010239A1 (es) | Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos | |
| DE69935599D1 (de) | Modifizierte hcv peptid-impfstoffe | |
| PE20010316A1 (es) | GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS, PEPTIDOS Y PROTEINAS FlgE RELACIONADOS Y SUS USOS | |
| CA2158024A1 (fr) | Nouveau polypeptide; adn codant le polypeptide; vecteur recombinant portant l'adn et virus recombinant utilisant le vecteur recombinant; son utilisation | |
| ES2079493T3 (es) | Proteina de membrana externa p1 y peptidos haemophilus influenzae tipo b. | |
| BR0209854A (pt) | Molécula de ácido nucléico recombinante, cassete de expressão, vetor, polipeptìdeo, composição de vacina, dispositivo de aceleração de partìcula, e, método para gerar uma resposta imune celular em um indivìduo | |
| ATE312923T1 (de) | Moraxella catarrhalis basb034 polypeptide und verwendungen davon | |
| WO2004056316A3 (fr) | Vaccins contre la proteine tat de vih servant a generer des anticorps neutralisants | |
| NO20006456L (no) | En mutant human hepatitt B viral stamme og anvendelser derav | |
| PE20231212A1 (es) | Polipeptidos variantes proteoliticamente estables de u1-agatoxina-ta1b para el control de plagas | |
| AR004191A1 (es) | Polipeptidos para inducir inmunidad protectora contra la tuberculosis, molecula de adn que los codifica, un vector de expresion, una celula huesped,una composicion farmaceutica, una vacuna, una proteina de fusion, un metodo para detectar la tuberculosis y kit de diagnostico. | |
| TH61176A (th) | กรดนิวคลีอิกที่ให้รหัสโพลีเพพไทด์ที่เกี่ยวกับการผ่านเข้าสู่เซลล์ของไวรัส prrs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |